Agios Pharmaceuticals, Inc. Investigated by Shareholder Rights Advocates – Investors Should Contact Levi & Korsinsky Regarding Potential Securities Law Violations – AGIO

NEW YORK, NY / ACCESS Newswire / December 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ:AGIO) concerning possible violations of federal securities laws. On November 19, 2025, Agios reported topline results from its RISE UP Phase 3 trial of Mitapivat in […]

Kenorland Minerals Reports Maiden Inferred Resource of 14.5 Mt at 5.47 g/t Au for 2.55 Million Ounces at the Frotet Project, Quebec, Where It Holds a 4% NSR Royalty

Vancouver, British Columbia–(Newsfile Corp. – December 16, 2025) – Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) (“Kenorland” or the “Company“) is pleased to announce a maiden Inferred Mineral Resource of 14.5 Mt at 5.47 g/t for 2.55 million ounces (Moz) of gold for the Regnault gold deposit at the Frotet Project (the “Project“)

Advanced Gold Announces Private Placement and Appointment of Director

Toronto, Ontario–(Newsfile Corp. – December 16, 2025) – Advanced Gold Exploration Inc. (CSE: AUEX) (FSE: HZ2) (OTC Pink: AUHID) (“Advanced Gold” or the “Company“) is pleased to announce the appointment of Shahab Samimi to its Board of Directors. Mr. Samimi is an experienced investor and corporate director with a strong background in capital allocation and

Prophecy DeFi Announces Consolidation

Toronto, Ontario–(Newsfile Corp. – December 16, 2025) – Prophecy DeFi Inc. (CSE: PDFI) (“Prophecy DeFi” or the “Company“) is pleased to announce that it has filed articles of amendment to consolidate its issued and outstanding common shares (each, a “Common Share“) on the basis of fifty (50) pre-consolidation Common Shares for one (1) post-consolidation Common Share (the

Crombie REIT Announces December 2025 Monthly Distribution

New Glasgow, Nova Scotia–(Newsfile Corp. – December 16, 2025) – Crombie Real Estate Investment Trust (TSX: CRR.UN) (“Crombie”) today announced a distribution of $0.07500 per Unit for the period from December 1, 2025, to and including December 31, 2025. The distribution will be payable on January 15, 2026, to Unitholders of record as at December 31, 2025.

Envirotech Vehicles Unveils Exclusive AI Infrastructure Expansion Framework With AZIO AI

(NASDAQ:EVTV), HOUSTON and NEWPORT BEACH, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) — via IBN — Envirotech Vehicles, Inc. (NASDAQ:EVTV) (“EVTV” or the “Company”) today announced that it has entered into an exclusive strategic acquisition framework with AZIO AI Corporation (www.azioai.ai), a rapidly scaling AI infrastructure company delivering high-performance compute, modular data-center solutions, and applied AI

Palvella Therapeutics Granted FDA Fast Track Designation for QTORIN(TM) 3.9% Rapamycin Anhydrous Gel (QTORIN(TM) rapamycin) for the Treatment of Angiokeratomas

(NASDAQ:PVLA), Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need With Fast Track designation, QTORIN(TM) rapamycin for angiokeratomas may be eligible for Accelerated Approval and Priority Review in the future, if applicable criteria are met Palvella plans to initiate a Phase

Vertero Strengthens Board of Directors with Appointment of Independent Chair R. Scott Greer

WOBURN, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Vertero Therapeutics, a clinical-stage biotechnology company breaking barriers in neurodegenerative disease treatment, today announced the appointment of R. Scott Greer as the new chair of its Board of Directors. Mr. Greer is a veteran in the life sciences industry with more than 30 years' experience as an

Repligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows

(NASDAQ:RGEN), WALTHAM, Mass., Dec. 16, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the launch of three new high-performance chromatography resins: AVIPure(R) HiPer(TM) AAV9 and AVIPure(R) HiPer(TM) AAV8 affinity resins, along with HiPer(TM) QA anion exchange resin, expanding the company's growing proteins portfolio and reinforcing

DeFi Technologies’ Subsidiary Valour Approved to List Valour Solana (VSOL) ETP on Brazil’s B3 Exchange

— Valour adds Solana exposure: DeFi Technologies' subsidiary Valour has received approval from B3 to list Valour Solana (VSOL), expanding its Brazilian digital asset ETP lineup beyond Bitcoin, Ethereum, XRP, and Sui, and giving investors BRL-denominated, locally listed exposure to Solana via their existing brokerage and custody rails. — Deepening Brazil's product suite: VSOL is

Scroll to Top